Close

Ratings by Goldman Sachs (Graig Suvannavejh)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
9/23/2022 Valneva SE VALN Maintain Neutral
(N/A)
 
 
  Details
5/25/2022 Halozyme Therapeutics halo Maintain Buy
(N/A)
 
 
  Details
11/15/2021 Harmony Biosciences Holdings Inc. HRMY Maintain Buy
(N/A)
 
 
  Details
11/15/2021 Halozyme Therapeutics HALO Maintain Buy
(N/A)
 
 
  Details
11/15/2021 TG Therapeutics TGTX Downgrade Sell
(Neutral)
33.17
(5.86)
-82.33% Details
11/9/2021 AUTL AUTL Maintain Neutral
(N/A)
 
 
  Details
8/24/2021 Horizon Therapeutics HZNP Maintain Neutral
(N/A)
 
 
  Details
8/17/2021 Terns Pharmaceuticals TERN Maintain Buy
(N/A)
 
 
  Details
8/11/2021 Vor Biopharma, Inc. VOR Maintain Sell
(N/A)
 
 
  Details
8/5/2021 Orchard Therapeutics ORTX Maintain Buy
(N/A)
 
 
  Details
8/4/2021 Rhythm Pharmaceuticals RYTM Maintain Sell
(N/A)
 
 
  Details
8/3/2021 TG Therapeutics TGTX Maintain Neutral
(N/A)
 
 
  Details
7/20/2021 Cytokinetics CYTK Maintain Neutral
(N/A)
 
 
  Details
7/13/2021 Ambrix Biopharma AMAM New Coverage Buy
(N/A)
21.32
(1.16)
-94.56% Details
7/13/2021 Ambrx Biopharma AMAM New Coverage Buy
(N/A)
21.32
(1.16)
-94.56% Details
6/30/2021 Cerevel Therapeutics CERE Maintain Buy
(N/A)
 
 
  Details
6/1/2021 Valneva SE VALN New Coverage Buy
(N/A)
25.98
(11.59)
-55.39% Details
5/18/2021 Rain Therapeutics RAIN New Coverage Buy
(N/A)
15.33
(4.87)
-68.23% Details
5/14/2021 Kodiak Sciences Inc. KOD Maintain Neutral
(N/A)
 
 
  Details
5/12/2021 Tricida TCDA Maintain Neutral
(Neutral)
 
 
  Details
4/20/2021 TG Therapeutics TGTX New Coverage Neutral
(N/A)
44.78
(5.86)
-86.91% Details
4/20/2021 Design Therapeutics Inc DSGN New Coverage Neutral
(N/A)
23.50
(16.21)
-31.02% Details
4/19/2021 Edgewise Therapeutics EWTX New Coverage Neutral
(N/A)
27.91
(10.48)
-62.45% Details
3/29/2021 Harmony Biosciences Holdings Inc. HRMY Upgrade Buy
(Neutral)
27.56
(54.70)
98.48% Details
3/11/2021 Flexion Therapeutics FLXN Maintain Neutral
(Neutral)
 
 
  Details
3/10/2021 Athira Pharma ATHA Maintain Neutral
(N/A)
 
 
  Details
3/8/2021 Kodiak Sciences Inc. KOD Maintain Neutral
(N/A)
 
 
  Details
3/8/2021 Cimarex Energy XEC Maintain Buy
(N/A)
 
 
  Details
3/4/2021 Orchard Therapeutics ORTX Maintain Buy
(N/A)
 
 
  Details
3/2/2021 Terns Pharmaceuticals TERN New Coverage Buy
(N/A)
24.64
(11.12)
-54.87% Details
3/2/2021 Immunocore Holdings IMCR New Coverage Neutral
(N/A)
48.36
(47.04)
-2.73% Details
3/2/2021 Gemini Therapeutics Inc. GMTX New Coverage Buy
(N/A)
15.20
(1.70)
-88.82% Details
3/2/2021 Vor Biopharma, Inc. VOR New Coverage Sell
(N/A)
44.96
(4.01)
-91.08% Details
2/25/2021 Halozyme Therapeutics HALO Maintain Buy
(N/A)
 
 
  Details
2/18/2021 Insmed INSM Maintain Buy
(N/A)
 
 
  Details
2/16/2021 Kodiak Sciences Inc. KOD Maintain Neutral
(N/A)
 
 
  Details
2/10/2021 Orchard Therapeutics ORTX Maintain Buy
(N/A)
 
 
  Details
2/3/2021 Arcutis Biotherapeutics Inc. ARQT Maintain Buy
(N/A)
 
 
  Details
2/1/2021 Cimarex Energy XEC Maintain Neutral
(N/A)
 
 
  Details
12/16/2020 Cimarex Energy XEC Upgrade Buy
(Neutral)
38.48
(87.20)
126.61% Details
12/10/2020 Cimarex Energy XEC Maintain Neutral
(N/A)
 
 
  Details
12/10/2020 Ceres CERE New Coverage Buy
(N/A)
16.06
(30.63)
90.72% Details
11/13/2020 Kodiak Sciences Inc. KOD Downgrade Neutral
(Buy)
119.99
(7.78)
-93.52% Details
11/11/2020 Jazz Pharmaceuticals JAZZ Maintain Sell
(N/A)
 
 
  Details
11/9/2020 Arcutis Biotherapeutics Inc. ARQT Upgrade Buy
(Neutral)
18.66
(19.84)
6.32% Details
10/29/2020 Cytokinetics CYTK New Coverage Neutral
(N/A)
16.33
(48.62)
197.73% Details
10/20/2020 Prelude Therapeutics PRLD New Coverage Neutral
(N/A)
31.00
(7.34)
-76.32% Details
9/21/2020 Immatics IMTX New Coverage Buy
(N/A)
9.19
(10.34)
12.51% Details
9/14/2020 Jazz Pharmaceuticals JAZZ Downgrade Sell
(Neutral)
139.10
(133.09)
-4.32% Details
9/14/2020 Harmony Biosciences Holdings Inc. HRMY New Coverage Neutral
(N/A)
44.39
(48.11)
8.38% Details
8/25/2020 Tricida TCDA Downgrade Neutral
(Buy)
10.11
(12.09)
19.58% Details
8/20/2020 Orchard Therapeutics ORTX Maintain Buy
(N/A)
 
 
  Details
8/20/2020 Flexion Therapeutics FLXN New Coverage Neutral
(N/A)
12.54
(9.12)
-27.27% Details
8/7/2020 Insmed INSM Maintain Buy
(N/A)
 
 
  Details
6/17/2020 Momenta Pharmaceuticals MNTA Maintain Neutral
(N/A)
 
 
  Details
6/16/2020 Momenta Pharmaceuticals MNTA Maintain Neutral
(N/A)
 
 
  Details
5/13/2020 Halozyme Therapeutics HALO Maintain Buy
(N/A)
 
 
  Details
5/11/2020 Bicycle Therapeutics BCYC Maintain Buy
(N/A)
 
 
  Details
5/8/2020 AUTL AUTL Maintain Neutral
(N/A)
 
 
  Details
5/6/2020 Portola Pharmaceuticals PTLA Maintain Neutral
(N/A)
 
 
  Details
3/12/2020 Momenta Pharmaceuticals MNTA New Coverage Neutral
(N/A)
29.15
(52.48)
80.03% Details
3/3/2020 Kodiak Sciences Inc. KOD New Coverage Buy
(N/A)
63.97
(7.78)
-87.84% Details
3/2/2020 Portola Pharmaceuticals PTLA Maintain Neutral
(N/A)
 
 
  Details
2/27/2020 Horizon Therapeutics HZNP Maintain Neutral
(N/A)
 
 
  Details
2/25/2020 Arcutis Biotherapeutics Inc. ARQT New Coverage Neutral
(N/A)
27.05
(19.84)
-26.65% Details
2/5/2020 Insmed INSM Maintain Buy
(N/A)
 
 
  Details
1/10/2020 Portola Pharmaceuticals PTLA Maintain Neutral
(N/A)
 
 
  Details
1/8/2020 Rhythm Pharmaceuticals RYTM New Coverage Sell
(N/A)
22.34
(25.44)
13.88% Details
1/8/2020 Halozyme Therapeutics HALO New Coverage Buy
(N/A)
18.05
(42.07)
133.07% Details
1/8/2020 Horizon Therapeutics HZNP New Coverage Neutral
(N/A)
36.22
(108.08)
198.4% Details
11/8/2019 Portola Pharmaceuticals PTLA New Coverage Neutral
(N/A)
28.41
(18.03)
-36.54% Details
11/1/2019 Insmed INSM Maintain Buy
(N/A)
 
 
  Details
10/31/2019 Insmed INSM Maintain Buy
(N/A)
 
 
  Details
9/24/2019 Krystal Biotech KRYS New Coverage Neutral
(N/A)
48.98
(61.09)
24.72% Details
9/11/2019 Bicycle Therapeutics BCYC Upgrade Buy
(Neutral)
7.15
(21.86)
205.73% Details
9/3/2019 Insmed INSM New Coverage Buy
(N/A)
16.44
(22.72)
38.2% Details
6/27/2019 Tricida TCDA New Coverage Buy
(N/A)
35.15
(12.09)
-65.6% Details
6/17/2019 Bicycle Therapeutics BCYC New Coverage Neutral
(N/A)
12.40
(7.15)
-42.34% Details
12/17/2018 Orchard Therapeutics ORTX Upgrade Buy
(Neutral)
15.00
(0.49)
-96.73% Details
12/17/2018 Zealand Pharma A/S ZEAL Downgrade Neutral
(Buy)
13.09
(17.59)
34.38% Details
11/26/2018 Orchard Therapeutics ORTX New Coverage Neutral
(N/A)
16.04
(15.00)
-6.48% Details